Back
Jasper Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
16
JSPR
Jasper Therapeutics, Inc.
Last Price:
$1.85
Seasonality Move:
-19.89%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiJasper Therapeutics, Inc. Stock Forecast
-
Is Jasper Therapeutics, Inc. Stock Undervalued?The current Jasper Therapeutics, Inc. [JSPR] share price is $1.86. The Score for JSPR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
JSPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Jasper Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Jasper Therapeutics, Inc. Stock Rating
Data Unavailable
Jasper Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
jaspertherapeutics.com
52-Week Data
52-Week High:
24.01
52-Week Low:
1.39
Prediction Charts
Market Cap:
52.1M
Price in USD:
1.86
Volume:
2M
Beta:
3.27
Technical Analysis
SMA50:
2.12
SMA100:
2.47
SMA200:
3.74
52-Wk Change:
-91.94%
Stock Predictions
-
Is Jasper Therapeutics, Inc. stock public?Yes, Jasper Therapeutics, Inc. is a publicly traded company.
-
What is the Jasper Therapeutics, Inc. stock quote today?The Jasper Therapeutics, Inc. stock price is 1.86 USD today.
-
How to buy Jasper Therapeutics, Inc. stock online?You can buy Jasper Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.59 | 1.68 | 1.68 | 1.58 |
| Nov-17 | 1.70 | 1.79 | 1.83 | 1.63 |
| Nov-18 | 1.71 | 1.83 | 1.92 | 1.71 |
| Nov-19 | 1.83 | 1.85 | 1.85 | 1.76 |
| Nov-20 | 1.85 | 1.76 | 1.97 | 1.76 |
| Nov-21 | 1.70 | 1.70 | 1.79 | 1.68 |
| Nov-24 | 1.72 | 1.72 | 1.83 | 1.70 |
| Nov-25 | 1.75 | 1.75 | 1.80 | 1.71 |
| Nov-26 | 1.75 | 1.75 | 1.78 | 1.68 |
| Nov-28 | 1.75 | 1.84 | 1.88 | 1.74 |
| Dec-1 | 1.82 | 1.72 | 1.82 | 1.70 |
| Dec-2 | 2.14 | 1.58 | 2.42 | 1.55 |
| Dec-3 | 1.48 | 1.65 | 1.66 | 1.39 |
| Dec-4 | 1.60 | 1.86 | 1.89 | 1.59 |
Jasper Therapeutics, Inc. Earnings
Data Unavailable
Jasper Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $1.51 per share.
* Jasper Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.